Patents by Inventor Frank R. Atherton

Frank R. Atherton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4250085
    Abstract: Peptide derivatives provided by the present invention are compounds of the general formula ##STR1## wherein R.sup.1 represents a hydrogen atom or the methyl or hydroxymethyl group or a mono-, di- or trihalomethyl mgroup; R.sup.2 represents the characterizing group of an .alpha.-amino acid of the type normally found in proteins or a lower alkyl or hydroxy- (lower alkyl) group other than the characterising group of an .alpha.-amino acid of the type normally found in proteins; R.sup.3 represents a lower alkyl, lower cycloalkyl, lower alkenyl, aryl or aryl-(lower alkyl) group; R.sup.4 represents a hydrogen atom or a lower alkyl group; n stands for 1,2 or 3; the configuration at the carbon atom designated as (a) is (R) when R.sup.1 represents other than a hydrogen atom and the configuration at the carbon atom designated as (b) is (L) when R.sup.2 represents other than a hydrogen atom, and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: December 20, 1978
    Date of Patent: February 10, 1981
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Frank R. Atherton, Michael J. Hall, Cedric H. Hassall, Robert W. Lambert, Peter S. Ringrose
  • Patent number: 4143134
    Abstract: The present disclosure relates to halo-phosphonopeptides. The subject compounds are antibacterial agents and also potentiate the activity of antibiotics.
    Type: Grant
    Filed: July 13, 1977
    Date of Patent: March 6, 1979
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Frank R. Atherton, Michael J. Hall, Cedric H. Hassall, Robert W. Lambert, Peter S. Ringrose
  • Patent number: 4134972
    Abstract: Compositions having antibiotic properties containing as antibiotic potentiators peptides of the formula ##STR1## wherein R.sup.1 represents a hydrogen atom or a lower alkyl, lower cycloalkyl, (lower cycloalkyl)-(lower alkyl), aryl or aryl(lower alkyl) group (said group being optionally substituted as the case may require by one or more amino, hydroxy, thio, methylthio, carboxy or guanidino groups so as to form the characterizing group of a naturally occurring L .alpha.-amino acid);R.sup.2 and R.sup.3 each represent the characterizing group of an .alpha.-amino acid of the type normally found in proteins with the proviso that R.sup.3 cannot represent a hydrogen atom when n is zero and R.sup.1 is a hydrogen atom or the phenyl group; R.sup.4 represents a hydroxy or methyl group; n stands for zero, 1, 2 or 3; and single asterisks denote that the configuration at the carbon atom so-marked is L when R.sup.2 or R.sup.
    Type: Grant
    Filed: November 11, 1977
    Date of Patent: January 16, 1979
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Frank R. Atherton, Michael J. Hall, Cedric H. Hassall, Peter S. Ringrose, Robert W. Lambert
  • Patent number: 4128542
    Abstract: There is provided peptide derivatives of the general formula ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 each represent the characterizing group of an .alpha.-amino acid of the type normally found in proteins; R.sup.4 represents a hydroxy or methyl group; n stands for zero, 1, 2 or 3; the configuration at the carbon atoms designated as (a), (b) and (c) is L (when R.sup.1 or R.sup.2 .noteq. H); and the configuration at the carbon atom designated as (d) is (R) (when R.sup.3 .noteq. H)and pharmaceutically acceptable salts thereof.The above compounds exhibit antibacterial activity against various microorganisms.
    Type: Grant
    Filed: July 5, 1977
    Date of Patent: December 5, 1978
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Frank R. Atherton, Michael J. Hall, Cedric H. Hassall, Robert W. Lambert, Peter S. Ringrose
  • Patent number: 4127649
    Abstract: Compositions having antibiotic properties containing as antibiotic potentiators peptides of the formula ##STR1## wherein R.sup.1 represents a hydrogen atom or a lower alkyl, lower cycloalkyl, (lower cycloalkyl)-(lower alkyl), aryl or aryl-(lower alkyl) group (said group being optionally substituted as the case may require by one or more amino, hydroxy, thio, methylthio, carboxy or guanidino groups so as to form the characterizing group of a naturally occurring L .alpha.-amino acid);R.sup.2 and R.sup.3 each represent the characterizing group of an .alpha.-amino acid of the type normally found in proteins with the proviso that R.sup.3 cannot represent a hydrogen atom when n is zero and R.sup.1 is a hydrogen atom or the phenyl group; R.sup.4 represents a hydroxy or methyl group; n stands for zero, 1, 2 or 3; and single asterisks denote that the configuration at the carbon atom so-marked is L when R.sup.2 or R.sup.
    Type: Grant
    Filed: May 23, 1977
    Date of Patent: November 28, 1978
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Frank R. Atherton, Michael J. Hall, Cedric H. Hassall, Peter S. Ringrose, Robert W. Lambert